BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38568892)

  • 21. Machine Learning for Prediction of Non-Small Cell Lung Cancer Based on Inflammatory and Nutritional Indicators in Adults: A Cross-Sectional Study.
    Wang Q; Liang T; Li Y; Liu X
    Cancer Manag Res; 2024; 16():527-535. PubMed ID: 38832344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
    Zhang Y; Liu H; Chang C; Yin Y; Wang R
    PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Machine learning based on clinico-biological features integrated
    Ren C; Zhang J; Qi M; Zhang J; Zhang Y; Song S; Sun Y; Cheng J
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1538-1549. PubMed ID: 33057772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung.
    Chen Z; Yi L; Peng Z; Zhou J; Zhang Z; Tao Y; Lin Z; He A; Jin M; Zuo M
    Front Oncol; 2022; 12():949111. PubMed ID: 36505773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Ruan D; Fang J; Teng X
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of Pulmonary Nodules in 2-[
    Alves VM; Dos Santos Cardoso J; Gama J
    Nucl Med Mol Imaging; 2024 Feb; 58(1):9-24. PubMed ID: 38261899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shape and texture analyses based on conventional MRI for the preoperative prediction of the aggressiveness of pituitary adenomas.
    Wang X; Dai Y; Lin H; Cheng J; Zhang Y; Cao M; Zhou Y
    Eur Radiol; 2023 May; 33(5):3312-3321. PubMed ID: 36738323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive
    Cui Y; Lin Y; Zhao Z; Long H; Zheng L; Lin X
    Front Immunol; 2022; 13():994917. PubMed ID: 36466929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Fluorodeoxyglucose Positron Emission Tomography Radiomics Features with Clinicopathological Factors and Prognosis in Lung Squamous Cell Cancer.
    Erol M; Önner H; Küçükosmanoğlu İ
    Nucl Med Mol Imaging; 2022 Dec; 56(6):306-312. PubMed ID: 36425277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer.
    Jiang C; Zhao M; Hou S; Hu X; Huang J; Wang H; Ren C; Pan X; Zhang T; Wu S; Zhang S; Sun B
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-Dimensional Convolutional Neural Network-Based Prediction of Epidermal Growth Factor Receptor Expression Status in Patients With Non-Small Cell Lung Cancer.
    Huang X; Sun Y; Tan M; Ma W; Gao P; Qi L; Lu J; Yang Y; Wang K; Chen W; Jin L; Kuang K; Duan S; Li M
    Front Oncol; 2022; 12():772770. PubMed ID: 35186727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Utility of PET/CT Metabolic Parameters Measured Based on Fixed Percentage Threshold of SUVmax and Adaptive Iterative Algorithm in the New Revised FIGO Staging System for Stage III Cervical Cancer.
    Zhang Y; Hu Y; Zhao S; Cui C
    Front Med (Lausanne); 2021; 8():680072. PubMed ID: 34395472
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.